Jon Marc Wigginton, Senior VP, Clinical Development at MACROGENICS INC (MGNX), sold 5,000 shares at $20.52 ($103K) on 2014-08-18, disclosed to the SEC on 2014-08-19.
Scheduled sale ($103k) by Senior VP, Clinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MGNX | SELL | 2017-10-26 | $200K | — | Filing → |
| MGNX | SELL | 2017-06-06 | $100K | — | Filing → |
| MGNX | SELL | 2017-04-20 | $300K | — | Filing → |